Jaguar Health announces 1-for-25 reverse stock split effective March 24 to meet Nasdaq compliance

Jaguar Health, Inc.

Reverse split at 1-for-25 ratio, effective March 24, 2025 at 12:01 am ET.
Purpose: support compliance with Nasdaq listing standards and attract institutional investors.
No fractional shares; stockholders otherwise entitled to fractional shares receive cash in lieu.
New CUSIP number for post-split common stock is 47010C888.
Stockholder approval obtained at March 13, 2025 special meeting.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Jaguar Health, Inc.: Filed Ninth Amendment to certificate of incorporation to effect a 1-for-25 reverse stock split of common stock (effective 2025-03-24).

Change: charter amendment
Effective: 2025-03-24

Exact text from the filing

on March 18, 2025, the Company filed the Ninth Amendment with the Secretary of State of the State of Delaware. The Reverse Stock Split will become effective

View on SEC.gov

23 governance changes filed in the last 30 days. Browse all governance changes →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-040784

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.